Here are the S-3 shelf registrations from Rhythm Pharmaceuticals, Inc. (RYTM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow RYTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RYTM filings page.
Rhythm Pharmaceuticals, Inc. filed a shelf registration that registers resale of 2,395,831 shares of common stock issuable upon conversion of Series A Convertible Preferred Stock and a sales agreement to offer up to $200,000,000 of common stock under an at‑the‑market style arrangement with TD Securities (USA) LLC.
The selling stockholders’ resale will not provide proceeds to the company; the sales agreement permits the company to issue and sell shares from time to time after the effective date, with specific terms to be provided in prospectus supplements.